Taysha Gene Therapies (TSHA) Times Interest Earned (2022 - 2025)
Taysha Gene Therapies (TSHA) has disclosed Times Interest Earned for 4 consecutive years, with -$2358.3 as the latest value for Q4 2025.
- Quarterly Times Interest Earned fell 160.3% to -$2358.3 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1753.9 through Dec 2025, down 95.61% year-over-year, with the annual reading at -$1753.9 for FY2025, 95.61% down from the prior year.
- Times Interest Earned hit -$2358.3 in Q4 2025 for Taysha Gene Therapies, down from -$2268.3 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$11.05 in Q3 2023 to a low of -$6206.4 in Q1 2022.
- Historically, Times Interest Earned has averaged -$1082.4 across 4 years, with a median of -$813.91 in 2024.
- Biggest five-year swings in Times Interest Earned: skyrocketed 99.81% in 2023 and later tumbled 9668.19% in 2024.
- Year by year, Times Interest Earned stood at -$41.35 in 2022, then skyrocketed by 44.9% to -$22.79 in 2023, then tumbled by 3876.23% to -$906.0 in 2024, then plummeted by 160.3% to -$2358.3 in 2025.
- Business Quant data shows Times Interest Earned for TSHA at -$2358.3 in Q4 2025, -$2268.3 in Q3 2025, and -$1573.7 in Q2 2025.